Skip to main content

Table 1 Univariate and multivariate analyses of factors associated with HCC patient overall survival

From: A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming

Variables

Univariate analysis

Multivariate analysis

RRb

SE

95%

P value

RRb

SE

95%

P value

YAP

1.819

0.233

1.151–2.875

0.01

1.717

0.235

1.083–2.721

0.021

Age

1.014

0.01

0.995–1.033

0.159

—

—

—

0.081

Gender

1.215

0.255

0.737–2.002

0.444

—

—

—

0.324

Tumor nodule

0.259

1.113

0.032–2.077

0.045

0.49

0.322

0.261–0.922

0.027

Lymph node metastases

0.899

0.232

0.570–1.416

0.645

—

—

—

0.762

HBV

0.985

0.149

0.736–1.318

0.917

—

—

—

0.724

Venous invasion

0.618

0.152

0.459–0.832

0.002

0.414

0.305

0.227–0.752

0.004

Liver cirrhosis

0.812

0.178

0.573–1.150

0.241

—

—

—

0.550

  1. YAP yes-associated protein 1, HCC hepatocellular carcinoma, HBV hepatitis B virus, SE standard error
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us